Gregory Phillips
Obstetrics & Gynecology · Shreveport, LANPI 1679784607
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 295 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 18.7% — the pattern of someone who eats at a lot of different presentations.
Across 295 payments — averaging $16.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$920
- AbbVie$673
- Astellas Pharma US Inc$302
- Currax Pharmaceuticals LLC$278
- Sumitomo Pharma America, Inc.$272
- Shield Therapeutics Inc$256
- plus $2K from 31 others
Across 10 payments — averaging $6703.63 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$67K
What the payments were for
- Food & beverage$4,919100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 71 | $920 |
| AbbVie | 35 | $673 |
| Astellas Pharma US Inc | 19 | $302 |
| Currax Pharmaceuticals LLC | 21 | $278 |
| Sumitomo Pharma America, Inc. | 14 | $272 |
| Shield Therapeutics Inc | 13 | $256 |
| Bayer | 12 | $220 |
| Avion Pharmaceuticals | 16 | $219 |
| Lupin Inc. | 13 | $171 |
| Mayne Pharma Commercial LLC | 6 | $163 |
| Coopersurgical, Inc. | 5 | $160 |
| Organon | 12 | $150 |
| Sage Therapeutics, LLC | 8 | $141 |
| Pfizer | 9 | $121 |
| Myriad Women's Health, Inc. | 1 | $97 |
| Aspira Women's Health Inc | 1 | $96 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $82 |
| Hologic Sales And Service, LLC | 4 | $80 |
| Evofem Biosciences, Inc. | 5 | $77 |
| Axsome Therapeutics, Inc. | 3 | $51 |
| Agile Therapeutics, Inc. | 2 | $35 |
| Millicent US Inc | 2 | $34 |
| Johnson & Johnson | 2 | $34 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $34 |
| Exeltis, USA Inc. | 2 | $32 |
| Dexcom, Inc. | 1 | $27 |
| Supernus Pharmaceuticals, Inc. | 1 | $24 |
| Merck | 1 | $23 |
| Scynexis, Inc. | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Smith+Nephew | 1 | $19 |
| Avanos Medical | 1 | $17 |
| Vertex | 1 | $16 |
| Therapeuticsmd, Inc. | 1 | $16 |
| BD | 1 | $14 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
| Novartis | 1 | $12 |
How this compares
$4,919 in reported general payments places this provider in the 85th percentile of 608 obstetrics & gynecology providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 27 | $491 |
| Montelukast Sodium | 25 | $369 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Shreveport
- Catherine VanderloosShreveport$55K
- Joanna PooleShreveport$24K
- Ricky PaulShreveport$24K
- Erin GullattShreveport$11K
- James RobertsonShreveport$11K
- John HaynesShreveport$9K
- Kristy WaltmanShreveport$7K
- Veronica GillispieNew Orleans$117K
- Rachel Bezdekla Place$105K
- Earl PeeperNew Orleans$95K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.